XML 34 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Liquidity and Management's Plans - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 22 Months Ended
Jul. 14, 2018
Jun. 11, 2018
Apr. 19, 2018
Feb. 06, 2018
Jul. 18, 2017
May 31, 2017
Sep. 13, 2016
Jul. 31, 2017
Jun. 30, 2018
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Conversion Of Stock [Line Items]                        
Net proceeds from sale of common stock and warrants                   $ 10,728,132 $ 0  
Net proceeds from sale of common stock                   192,322 $ 3,426,050  
Bridge Financing Notes [Member] | Note Purchase Agreement [Member]                        
Conversion Of Stock [Line Items]                        
Interest rate           10.00%            
Maturity date           Sep. 30, 2017            
Bridge Financing Notes [Member] | Note Purchase Agreement [Member] | Maximum [Member]                        
Conversion Of Stock [Line Items]                        
Aggregate principal amount           $ 1,500,000            
Bridge Financing Note One [Member] | Note Purchase Agreement [Member]                        
Conversion Of Stock [Line Items]                        
Aggregate principal amount           500,000            
Bridge Financing Note Two [Member] | Note Purchase Agreement [Member]                        
Conversion Of Stock [Line Items]                        
Aggregate principal amount           500,000            
Bridge Financing Note Three [Member] | Note Purchase Agreement [Member]                        
Conversion Of Stock [Line Items]                        
Aggregate principal amount           $ 500,000            
Qualified Financing [Member] | Note Purchase Agreement [Member] | Minimum [Member]                        
Conversion Of Stock [Line Items]                        
Net proceeds from equity or debt financing                   $ 5,000,000    
Merck GHI Financing Agreement [Member] | The Allonge [Member]                        
Conversion Of Stock [Line Items]                        
Aggregate principal amount   $ 1,000,000                    
Revised and extended maturity date for payment, terms   Six semi-annual payments                    
Principal payments includes accrued and unpaid interest   $ 166,667                    
Beginning date of debt maturity   Jan. 02, 2019                    
Ending date of debt maturity   Jul. 01, 2021                    
Merck GHI Financing Agreement [Member] | The Allonge [Member] | Subsequent Event [Member]                        
Conversion Of Stock [Line Items]                        
Accrued and unpaid interest $ 285,512                      
Stock Purchase Warrants [Member] | Bridge Financing Notes [Member] | Note Purchase Agreement [Member]                        
Conversion Of Stock [Line Items]                        
Class of warrant or right, exercise price of warrants or rights                     $ 19.50  
Class of warrant or right, number of securities called by warrants or rights                     5,634  
Warrants [Member] | Bridge Financing Notes [Member] | Note Purchase Agreement [Member]                        
Conversion Of Stock [Line Items]                        
Class of warrant or right, exercise price of warrants or rights               $ 17.25        
Class of warrant or right, number of securities called by warrants or rights               6,350        
February 2018 Public Offering [Member]                        
Conversion Of Stock [Line Items]                        
Stock issued during period, shares, new issues       2,841,152                
Shares issued, price per share       $ 3.25                
Gross proceeds from sale of common stock and warrants       $ 12,000,000                
Net proceeds from sale of common stock and warrants       $ 10,700,000                
Sale of stock, description of transaction                   Each unit included one share of common stock and one common warrant to purchase 0.5 share of common stock at an exercise price of $3.25 per share. Each pre-funded unit included one pre-funded warrant to purchase one share of common stock for an exercise price of $0.01 per share, and one common warrant to purchase 0.5 share of common stock at an exercise price of $3.25 per share.    
Class of warrant or right, number of securities called by each warrant or right       0.5                
Class of warrant or right, exercise price of warrants or rights       $ 3.25                
Warrants exercisable period       5 years                
February 2018 Public Offering [Member] | Pre-funded Units [Member]                        
Conversion Of Stock [Line Items]                        
Stock issued during period, shares, new issues       851,155                
Shares issued, price per share       $ 3.24                
February 2018 Public Offering [Member] | Pre-funded Warrants [Member]                        
Conversion Of Stock [Line Items]                        
Class of warrant or right, exercise price of warrants or rights       $ 0.01                
Warrants exercised     851,155           673,077 851,155    
July 2017 Public Offering [Member]                        
Conversion Of Stock [Line Items]                        
Stock issued during period, shares, new issues         18,164,195              
Shares issued, price per share         $ 0.40              
Gross proceeds from sale of common stock and warrants         $ 10,000,000              
Net proceeds from sale of common stock and warrants         $ 8,800,000              
Sale of stock, description of transaction                   Each unit included one twenty-fifth of a share of common stock and one common warrant to purchase one twenty-fifth of a share of common stock at an exercise price of $10.63 per share. Each pre-funded unit included one pre-funded warrant to purchase one twenty-fifth of a share of common stock for an exercise price of $0.25 per share, and one common warrant to purchase one twenty-fifth of a share of common stock at an exercise price of $10.63 per share.    
Class of warrant or right, number of securities called by each warrant or right         0.04              
Class of warrant or right, exercise price of warrants or rights         $ 10.63              
Warrants exercisable period         5 years              
July 2017 Public Offering [Member] | Bridge Financing Notes [Member]                        
Conversion Of Stock [Line Items]                        
Repayment of outstanding debt         $ 1,000,000     $ 1,000,000        
July 2017 Public Offering [Member] | Pre-funded Units [Member]                        
Conversion Of Stock [Line Items]                        
Stock issued during period, shares, new issues         6,835,805              
Shares issued, price per share         $ 0.39              
July 2017 Public Offering [Member] | Pre-funded Warrants [Member]                        
Conversion Of Stock [Line Items]                        
Class of warrant or right, number of securities called by each warrant or right         0.04              
Class of warrant or right, exercise price of warrants or rights         $ 0.25              
At the Market Offering [Member] | Sales Agreement [Member] | Cowen and Company, LLC [Member]                        
Conversion Of Stock [Line Items]                        
Aggregate gross proceeds from issuance of common stock                   $ 9,000,000    
Stock issued during period, value, new issues             $ 11,500,000          
Aggregate net proceeds from sale of common stock                   8,400,000    
Remaining availability under at the market offering                   2,500,000    
Net proceeds from sale of common stock                 $ 200,000 200,000    
Gross proceeds from sale of common stock                 $ 200,000 $ 200,000    
At the Market Offering [Member] | Sales Agreement [Member] | Maximum [Member] | Cowen and Company, LLC [Member]                        
Conversion Of Stock [Line Items]                        
Aggregate gross proceeds from issuance of common stock             $ 25,000,000          
At the Market Offering [Member] | Common Stock [Member] | Sales Agreement [Member] | Cowen and Company, LLC [Member]                        
Conversion Of Stock [Line Items]                        
Stock issued during period, shares, new issues                 104,043 104,043   476,054
Net proceeds from sale of common stock                 $ 200,000 $ 200,000    
Gross proceeds from sale of common stock                 $ 200,000 $ 200,000